Journal of Pain Research
A Comparative Cost-Consequence Analysis of Spinal Cord Stimulation and Magnetic Peripheral Nerve Stimulation for the Treatment of Painful Diabetic Peripheral Neuropathy in an Integrated Health System
Door Marshall David Bedder.
Inhoud in het Engels
Abstract
Background
Painful diabetic peripheral neuropathy (PDN) is common, progressive, and often refractory to drugs. Two neuromodulation options now carry US Food and Drug Administration indications for PDN, implanted spinal cord stimulation (SCS) and noninvasive magnetic peripheral nerve stimulation (mPNS). This study compares what the two cost an integrated health system over three years and sets those costs beside the clinical results each has published.